Department of Radiology, First Affiliated Hospital, Zhengzhou University Zhengzhou, Henan Province, China.
Clin Radiol. 2010 Aug;65(8):629-35. doi: 10.1016/j.crad.2010.01.023. Epub 2010 Jun 11.
To evaluate the mid-term safety and efficacy of a retrieval stent filter and 30mm balloon dilator in the treatment of Budd-Chiari syndrome (BCS) patients with chronic inferior vena cava (IVC) thrombosis.
Twenty-three consecutive patients with BCS and chronic IVC thrombosis were treated with a retrieval stent filter and a 30mm balloon dilator, and subsequently underwent color Doppler ultrasound follow-up at our hospital. Data relating to the technical success, angiographic and ultrasound results, mortality, morbidity, and final clinical outcome were collected retrospectively and follow-ups were performed 1, 3, 6, and 12 months after placement of the stent, and annually thereafter.
Stent filter placement and balloon dilation were technically successful in all patients, with no procedure-related complications. Removal of the stent filter was technically successful in 22 of 23 attempts, yielding a technical successful rate of 95.7% (95% confidence intervals (CI): 87%, 105%). Inferior vena cavagrams performed immediately before stent removal demonstrated that the IVC thrombus had completely resolved in all patients without pulmonary embolism. The mean primary patency rate 3, 6, 12, and 24 months after venoplasty was 0.91 (95% CI: 0.79-1.04), 0.87 (95% CI: 0.72-1.02), 0.87 (95% CI: 0.72-1.02), and 0.87 (95% CI: 0.72-1.02), respectively. The secondary patency rates were 1.00 throughout the follow-up period. All patients are alive with resolution of the symptoms at the time of this report.
The preliminary results indicate that the retrieval stent filter and 30mm balloon dilator are a safe and effective treatment for BCS patients with chronic IVC thrombosis.
评估回收支架滤器联合 30mm 球囊扩张在治疗慢性下腔静脉(IVC)血栓形成的布加综合征(BCS)患者中的中期安全性和疗效。
连续 23 例 BCS 合并慢性 IVC 血栓患者接受回收支架滤器联合 30mm 球囊扩张治疗,随后在我院进行彩色多普勒超声随访。回顾性收集技术成功率、血管造影和超声结果、死亡率、发病率和最终临床结果的数据,支架置入后 1、3、6 和 12 个月以及此后每年进行随访。
所有患者支架滤器置入和球囊扩张均获得技术成功,无与操作相关的并发症。23 次尝试中有 22 次成功取出支架滤器,技术成功率为 95.7%(95%置信区间:87%,105%)。在取出支架滤器前进行下腔静脉造影显示,所有患者 IVC 血栓完全溶解,无肺栓塞发生。支架成形术后 3、6、12 和 24 个月的平均初始通畅率分别为 0.91(95%置信区间:0.79-1.04)、0.87(95%置信区间:0.72-1.02)、0.87(95%置信区间:0.72-1.02)和 0.87(95%置信区间:0.72-1.02),二级通畅率在整个随访期间均为 1.00。本报告时所有患者均存活且症状缓解。
初步结果表明,回收支架滤器联合 30mm 球囊扩张是治疗慢性 IVC 血栓形成的 BCS 患者的一种安全有效的治疗方法。